Showing all 8 resultsSorted by popularity
SLU-PP-332 is a first-in-class pan-agonist of Estrogen-Related Receptors (alpha, beta, gamma) that recruits PGC-1alpha to upregulate mitochondrial oxidative phosphorylation. An oral exercise mimetic for investigating metabolic adaptation without physical exertion.
ERR pan-agonist for metabolic research at 1000mcg dosage. Investigate ERRalpha/beta/gamma activation and mitochondrial function.
ERR pan-agonist in 100mg capsule form for extended metabolic research. Study endurance and mitochondrial pathways.
SLU-PP-332 and BAM15 complementary blend for dual ERR activation and mitochondrial uncoupling research.
ERR pan-agonist for high-dose metabolic research at 50mg. Study ERR receptor activation and exercise mimetic pathways.
ERR pan-agonist for metabolic and endurance research at 20mg dosage. Research mitochondrial biogenesis and energy homeostasis.
ERR pan-agonist exercise mimetic at 5mg oral dosage. Study fatty acid oxidation and endurance pathway activation.
ERR pan-agonist for endurance and metabolic research at 500mcg dosage. Study mitochondrial biogenesis and exercise mimetic pathways.
End of content
End of content
No products in the cart.
